Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NanoSanguis, Inc. logo — company profile

NanoSanguis, Inc.

Founded 2015 Poland Poland 7 employees Seed Biotechnology

General Information

Company Name NanoSanguis, Inc.
Founded Year 2015
Location Poland Poland +1
Employees 7
Industries Biotechnology
Funding Stage Seed
Social

Get notified when NanoSanguis, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NanoSanguis, Inc.

NanoSanguis, Inc. is a biotechnology startup founded in 2015 with a mission to bring a safe and effective red blood cell substitute to the market. Originating from Warsaw University of Technology, the company emerged from a team of PhD candidates developing the technology of oxygen therapeutics. In December 2015, the startup received a significant boost by securing a Seed Round investment from Giza Polish Ventures to further propel its vision. NanoSanguis aims to democratize access to synthetic blood, offering it to every individual in need, irrespective of their origin, social status, or religious beliefs, embodying a humanitarian focus within the biotechnology space. Based in Poland, the company stands as a promising entity in the biotech landscape, holding potential for transformative impact and innovative advancements within the health and medical sectors.

Taxonomy: MedTech, Oxygen therapeutics, Synthetic blood, Medical research, Life sciences, Investment, VC funding

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
01 Jan 2016

NanoSanguis, Inc. Alternatives & Competitors

NanoSanguis, Inc. vs
Osler Diagnostics
Osler Diagnostics United Kingdom

Lab-quality diagnostics for anyone, anywhere, at any time.

Series C
123 employees
Health Care, Life Sciences
NanoSanguis, Inc. vs
GenoDeep
GenoDeep Iran

Cancer Screening Using AI

2-10 employees
AI, Biotechnology
NanoSanguis, Inc. vs
Aminolab
Aminolab

Pioneering sustainable solutions through advanced blood resource recycling technology.

Series Unknown
Waste Solution
Also compare with: NanoSanguis, Inc. vs Mercy BioAnalytics, Inc. Mercy BioAnalytics, Inc.

FAQ About NanoSanguis, Inc.

NanoSanguis is a company founded to bring to the market first safe and effective red blood cell substitute. The company has its origin in Warsaw University of Technology. We have started as a team of PhD candidates developing technology of oxygen therapeutics. In December 2015, together with two VC...
NanoSanguis, Inc. was founded in 2015.
NanoSanguis, Inc. is headquartered in Poland.
NanoSanguis, Inc. operates in the following industries: Biotechnology.
NanoSanguis, Inc. has approximately 7 employees.
NanoSanguis, Inc. has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to NanoSanguis, Inc. include Osler Diagnostics, GenoDeep, Aminolab, Mercy BioAnalytics, Inc., Cascade Metrix, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NanoSanguis, Inc. and Osler Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NanoSanguis, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes